A Rapid and Sensitive HPLC Method for the Determination of Naproxen in Plasma

Acta Pharmaceutica Turcica

Volumn 45, Issue 3, 2003, Pages 197-201

  Tashtoush, Bassam M ^a   Al Taani, Bashar M ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Fluorescence detection; HPLC; Naproxen; Plasma

Indexed keywords

ACETIC ACID DERIVATIVE; ACETONITRILE; AMPICILLIN; CAFFEINE; DICLOFENAC; DOPA; FAMOTIDINE; IBUPROFEN; NAPHTHYLACETIC ACID; NAPROXEN; NIFEDIPINE; PARACETAMOL; PHENYLPROPANOLAMINE; PHOSPHORIC ACID; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; DRUG ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LINEAR REGRESSION ANALYSIS; PH; RABBIT; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TECHNIQUE;

EID: 0347362672     PISSN: 1300638X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Anttila, M., (1977). Fluorometric determination of naproxen in serum. J. Pharm. Sci. 66: 433.
2. Baker, J. K. and Fifer, E. K., (1980). High-pressure liquid chromatographic identification of drugs used in management of arthritis. J. Pharm. Sci., 69: 590.
3. Broquair, M., Rovei, V. and Braithwaite R., (1981). Quantitative determination of naproxen in plasma by a simple high performance liquid chromatographic method. J. Chromatog. 224, 43.
4. Desager, J. P., Vanderbist, M. and Harvengt, C., (1976). Naproxen plasma levels in volunteers after single-dose administration by oral and rectal routes. J. Clin. Pharmacol., 16: 189.
5. Dusci, L. J. and Hackett, L. P., (1979). Determination of some anti-inflammatory drugs in serum by high-performance liquid chromatography. J. Chromatogr., 172: 516.
6. Golden W., (1980). Most antiarthritic agents injure GI mucosa. J. Am. Med. Assoc., 243: 408
7. Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gilman, A. G., (1996). Goodman and Gilman's The pharmacological Basis of Therapeutics. 9th edition. McGraw-Hill INC, New York, pp. 638-653.
8. Hirai, T., Matsumoto, S. and Kishi, I., (1997). Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction. J. Chromatogr. B. Biomed. Sci. and App., 692(2): 375.
9. Kimberly, R. P., Bowden, R. E., Keiser, H. R. and Poltz, P.H., (1978). Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am. J. Med., 64: 804.
10. Populaire, P., Terlain, B., Pascal, S. Decouvelaere, B., Lebreton, G., Renard, A. and Thomas, J. P., (1973). Biological behavior: serum levels; excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men. Ann. Pharm. Fr., 31: 679.
11. Runkel, R., Chaplin, M., Boost, G. Segre, E. and Forchielli, E., (1972). Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J. Pharm. Sci., 61: 703.
12. Runkel, R., Forchielli, E., Sevelius, H., Chaplin, M. and Segre, E., (1974). Nonlinear plasma level response to high doses of naproxen. Clin. Pharmacol. Ther., 15: 261.
13. Shimek, J. L., Rao, N. G. S. and Wahba Khalil S. K., (1982). An isocratic high-pressure liquid chromatographic determination of naproxen and desmethylnaproxen. J. Pharm. Sci., 71: 4.
14. Slattery, J. T. and Levy, G., (1979). Determination of naproxen and its desmethyl metabolite in human plasma or serum by high performance liquid chromatography. Clin. Biochem., 12: 100.
15. Upton, R. A., Buskin, J. N., Guentert, T. W., Williams, R. L. and Riegelman, S., (1986). Convenient and sensitive high performance liquid chromatography assay for ketoprofen, naproxen and other allied drugs in plasma or urine. J. Chromatogr., 190: 119.